Eli Lilly is requesting medical records from patients who took compounded versions of tirzepatide amid safety concerns and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental obesity pill monlunabant came in below market expectations.

The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month. Novo Nordisk's Wegovy Gets EU Backing to Treat ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

The Indiana Finance Authority approved the loans to support the proposed extension of the Citizens Energy system to provide ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...